Plunkett Research Online: Amphastar Pharmaceutical Inc

AMPHASTAR PHARMACEUTICAL INC (AMPH:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Manufactures injectable and inhalation products.....

Amphastar Pharmaceutical Inc
Ticker: AMPH
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 909 980-9484
Fax: 909 980-8296
Address: 11570 6th Street
Rancho Cucamonga, CA 91730 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Jack Zhang CEO/Chief Scientific Officer/Co-Founder/Director
William Peters CFO/Chief Accounting Officer/President, Subsidiary/Senior VP/Treasurer
See More
Manufactures injectable and inhalation products.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: